Cargando…
PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?
Research in cancer immunology is currently accelerating following a series of cancer immunotherapy breakthroughs during the last 5 years. Various monoclonal antibodies which block the interaction between checkpoint molecules PD-1 on immune cells and PD-L1 on cancer cells have been used to successful...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986262/ https://www.ncbi.nlm.nih.gov/pubmed/27532023 http://dx.doi.org/10.1186/s40425-016-0153-x |